Home/Filings/4/0001209191-22-053346
4//SEC Filing

Hsu Frank J. 4

Accession 0001209191-22-053346

CIK 0001814140other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 4:53 PM ET

Size

7.2 KB

Accession

0001209191-22-053346

Insider Transaction Report

Form 4
Period: 2022-10-07
Hsu Frank J.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-10-07+25,00025,000 total
  • Award

    Employee Stock Option (right to buy)

    2022-10-07+27,00027,000 total
    Exercise: $2.46Exp: 2032-10-07Common Stock (27,000 underlying)
Footnotes (2)
  • [F1]The shares are represented by restricted stock units, or RSUs, which vest in two equal installments on December 15, 2022 and June 15, 2023.
  • [F2]The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2022.

Issuer

Apexigen, Inc.

CIK 0001814140

Entity typeother

Related Parties

1
  • filerCIK 0001786723

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:53 PM ET
Size
7.2 KB